TRCT
MDWD icon

Tower Research Capital (TRC)’s MediWound MDWD Stock Holding History

Tower Research Capital (TRC)’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.1K Buy
1,805
+1,196
+196% +$20.8K ﹤0.01% 3200
2025
Q4 		$11.2K Sell
609
-291
-32% -$5.32K ﹤0.01% 3623
2025
Q3 		$16.2K Sell
900
-1,033
-53% -$19.1K ﹤0.01% 3486
2025
Q2 		$37.4K Buy
1,933
+1,371
+244% +$25.8K ﹤0.01% 3219
2025
Q1 		$8.72K Sell
562
-50
-8% -$895 ﹤0.01% 3858
2024
Q4 		$10.9K Sell
612
-230
-27% -$3.96K ﹤0.01% 3767
2024
Q3 		$15.2K Buy
842
+771
+1,086% +$14.1K ﹤0.01% 3421
2024
Q2 		$1.1K Sell
71
-129
-65% -$2.13K ﹤0.01% 5207
2024
Q1 		$2.85K Buy
+200
New +$2.74K ﹤0.01% 4975
2023
Q4 		– Sell
-151
Closed -$1.61K – 6070
2023
Q3 		$1.61K Sell
151
-886
-85% -$8.14K ﹤0.01% 5297
2023
Q2 		$11.1K Sell
1,037
-189
-15% -$2.04K ﹤0.01% 4020
2023
Q1 		$16K Sell
1,226
-3,059
-71% -$38.6K ﹤0.01% 3719
2022
Q4 		$58K Buy
4,285
+2,895
+208% +$29.3K ﹤0.01% 2241
2022
Q3 		$14K Buy
1,390
+860
+162% +$10.8K ﹤0.01% 4216
2022
Q2 		$7K Buy
+530
New +$7.01K ﹤0.01% 4804
2022
Q1 		– Sell
-452
Closed -$7K – 6370
2021
Q4 		$7K Sell
452
-338
-43% -$7.03K ﹤0.01% 4921
2021
Q3 		$18K Buy
+790
New +$21.1K ﹤0.01% 3828
2021
Q2 		– Sell
-718
Closed -$27K – 5689
2021
Q1 		$27K Buy
718
+212
+42% +$7.68K ﹤0.01% 3644
2020
Q4 		$13K Buy
506
+445
+730% +$11.5K ﹤0.01% 4151
2020
Q3 		$2K Sell
61
-174
-74% -$4.45K ﹤0.01% 4603
2020
Q2 		$5K Buy
235
+22
+10% +$314 ﹤0.01% 4280
2020
Q1 		$2K Sell
213
-1,068
-83% -$19.7K ﹤0.01% 2605
2019
Q4 		$28K Buy
1,281
+1,083
+547% +$22.5K ﹤0.01% 1707
2019
Q3 		$5K Sell
198
-477
-71% -$10.6K ﹤0.01% 3311
2019
Q2 		$16K Buy
675
+505
+297% +$15.6K ﹤0.01% 2300
2019
Q1 		$6K Buy
170
+37
+28% +$1.25K ﹤0.01% 2958
2018
Q4 		$4K Sell
133
-153
-53% -$5.94K ﹤0.01% 3050
2018
Q3 		$13K Buy
286
+69
+32% +$3.1K ﹤0.01% 2606
2018
Q2 		$11K Buy
217
+185
+578% +$7.96K ﹤0.01% 2737
2018
Q1 		$1K Sell
32
-65
-67% -$2.05K ﹤0.01% 3084
2017
Q4 		$3K Buy
97
+29
+43% +$976 ﹤0.01% 3090
2017
Q3 		$3K Sell
68
-284
-81% -$12.5K ﹤0.01% 3481
2017
Q2 		$17K Buy
+352
New +$16.4K ﹤0.01% 1311
2016
Q4 		– Sell
-71
Closed -$4K – 4177
2016
Q3 		$4K Buy
+71
New +$3.77K ﹤0.01% 2688
2016
Q1 		– Sell
-43
Closed -$3K – 4605
2015
Q4 		$3K Buy
+43
New +$2.71K ﹤0.01% 3467
2015
Q3 		– Sell
-36
Closed -$2K – 4461
2015
Q2 		$2K Buy
+36
New +$1.57K ﹤0.01% 3745
2015
Q1 		– Sell
-6
Closed – – 4719
2014
Q4 		$0 Sell
6
-580
-99% -$23.8K ﹤0.01% 4402
2014
Q3 		$26K Buy
+586
New +$33.7K ﹤0.01% 2086

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s MDWD Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its MediWound (MDWD) stake by 196% in Q1 2026, buying an estimated $20.8K and bringing the position to 1,805 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Tower Research Capital (TRC) first reported a position in MDWD in Q3 2014 and has held it in 38 quarters since. The position peaked at $58K in Q4 2022. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

  • Tower Research Capital (TRC) held 1,805 shares of MediWound worth $29.1K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,196 MediWound shares in Q1 2026, an estimated $20.8K.
  • MediWound made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3200 holding.
  • Tower Research Capital (TRC) first reported a position in MediWound in Q3 2014 and has held it in 38 quarters since.
  • Tower Research Capital (TRC)'s MediWound position peaked at $58K in Q4 2022.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.